ACUTE MYELOID LEUKAEMIA REFRACTORY

Clinical trials for ACUTE MYELOID LEUKAEMIA REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOID LEUKAEMIA REFRACTORY trials appear

Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

First patients receive experimental drug for aggressive leukemias

Disease control Terminated

This study was the first time a new drug called SAR443579 was tested in people. It aimed to find a safe dose and see if it could help control several aggressive blood cancers that had come back or stopped responding to other treatments. The trial included both adults and children…

Matched conditions: ACUTE MYELOID LEUKAEMIA REFRACTORY

Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

ACUTE MYELOID LEUKAEMIA REFRACTORY

Get alerted when new ACUTE MYELOID LEUKAEMIA REFRACTORY trials appear

First patients receive experimental drug for aggressive leukemias